Active Ingredient: TASIMELTEON
Proprietary Name: HETLIOZ LQ
Dosage Form; Route of Administration: SUSPENSION; ORAL
Strength: 4MG/ML
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code:
Application Number: N214517
Product Number: 001
Approval Date: Dec 1, 2020
Applicant Holder Full Name: VANDA PHARMACEUTICALS INC
Marketing Status:
Prescription
Patent and Exclusivity Information